|

Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery

RECRUITINGN/ASponsored by Mahidol University
Actively Recruiting
PhaseN/A
SponsorMahidol University
Started2024-01-02
Est. completion2025-12-31
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06216002

Summary

Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Age \>,= 18 years
* Patients undergoing elective gynecologic-oncology surgery

Exclusion Criteria:

* Unable to communicate Thai
* Unable to understand the questionnaire
* Preexisting neuromuscular disease
* Preexisting disease involved wrist that may affect the nerve stimulator examination

Conditions6

CancerFrailtyGeneral Anesthetic Drug Adverse ReactionGynecologic CancerNeuromuscular BlockadeSurgical Complication

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.